Trademark Overview
On Wednesday, July 15, 2026, a trademark application was filed for XENVERZY with the United States Patent and Trademark Office. The USPTO has given the XENVERZY trademark a serial number of 99942178. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 15, 2026. This trademark is owned by ZENTALIS PHARMACEUTICALS, INC.. The XENVERZY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; Pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases